Skip to main content

Market Overview

argenx to Report First Quarter 2021 Financial Results and Business Update on May 14, 2021


May 7, 2021

Breda, the Netherlands – argenx ((Euronext &amp, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Friday, May 14, 2021 at 2:30 p.m. CET (8:30 a.m. ET) to discuss its first quarter 2021 financial results and provide a business update.

A webcast of the live call may be accessed on the Investors section of the argenx website at A replay of the webcast will be available on the argenx website for approximately one year following the call.

Dial-in numbers:
Please dial in 15 minutes prior to the live call.

Belgium                 0800 389 13
France                 0805 102 319
Netherlands                0800 949 4506
United Kingdom         0800 279 9489
United States 1 844 808 7140
International                    1 412 902 0128

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States, Japan and Switzerland. For more information, visit and follow us on LinkedIn at and Twitter at

For further information, please contact:

Kelsey Kirk

Joke Comijn


Beth DelGiacco

Michelle Greenblatt

Primary Logo

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at